Manuscripts
Showing 1533 manuscripts.
Infectious immune complexes in HIV-1-infected patients.
Citation
Susan A. Fiscus, James D. Folds, Charles van der Horst. Infectious immune complexes in HIV-1-infected patients.. Viral Immunology. 1993. 6: 135-41.Year
1993
Journal
Viral Immunology
Performance evaluation in multicenter clinical trials: development of a model by the AIDS Clinical Trials Group
Citation
Linda L. Rosendorf, Urania Dafni, David A. Amato, Barbara Lunghofer, John G. Bartlett, John M. Leedom, Diane W. Wara, John A. Armstrong, Catherine Godfrey, Eivind Sukkestad, Georg W. Counts. Performance evaluation in multicenter clinical trials: development of a model by the AIDS Clinical Trials Group. Controlled Clinical Trials. 1993. 14: 523-7.Year
1993
Journal
Controlled Clinical Trials
Effect of human immunodeficiency virus infection on the growth of young children. Duke pediatric AIDS clinical trials unit
Citation
Ross E. McKinney, J. W. Robertson. Effect of human immunodeficiency virus infection on the growth of young children. Duke pediatric AIDS clinical trials unit. Journal of Pediatrics. 1993. 123: 579-82.Year
1993
Journal
Journal of Pediatrics
Phase I Evaluation of Zidovudine Adminstered to Infants Exposed at Birth to the Human Immunodeficiency Virus
Citation
F. Boucher. Phase I Evaluation of Zidovudine Adminstered to Infants Exposed at Birth to the Human Immunodeficiency Virus. Journal of Pediatrics. 1993. 122: 137-144.Year
1993
Journal
Journal of Pediatrics
The Pharmacokinetics and Safety of Zidovudine in the Third Trimester of Pregnancy for Women Infected With Human Immunodeficiency Virus and Their Infants: Phase I Acquired Immunodeficiency Syndrome Clinical Trials Group Study (Protocol 082)
Citation
Mary Jo O'Sullivan. The Pharmacokinetics and Safety of Zidovudine in the Third Trimester of Pregnancy for Women Infected With Human Immunodeficiency Virus and Their Infants: Phase I Acquired Immunodeficiency Syndrome Clinical Trials Group Study (Protocol 082). American Journal of Obstetrics and Gynecology. 1993. 168: 1510-1516.Year
1993
Journal
American Journal of Obstetrics and Gynecology
Enhanced p24 Antigen Detection in Sera from HIV-Infected Children
Citation
E. Walter. Enhanced p24 Antigen Detection in Sera from HIV-Infected Children. Pediatric Infectious Disease Journal. 1993. 12: 94-96.Year
1993
Journal
Pediatric Infectious Disease Journal
Uric acid and didanosine compliance in AIDS clinical trials: an analysis of AIDS Clinical Trials Group protocols 116A and 116B/117.
Citation
D. Richardson, Song-Heng Liou, James O. Kahn. Uric acid and didanosine compliance in AIDS clinical trials: an analysis of AIDS Clinical Trials Group protocols 116A and 116B/117.. Journal of Acquired Immune Deficiency Syndromes. 1993. 6: 1212-23.Year
1993
Journal
Journal of Acquired Immune Deficiency Syndromes
2',3'-dideoxycytidine (ddC) toxic neuropathy: a study of 52 patients
Citation
A. Berger, Joseph Arezzo, Herbert H. Schaumburg, Gail Skowron, Thomas C. Merigan, Sam Bozzette, Douglas D. Richman, Whaijen Soo. 2',3'-dideoxycytidine (ddC) toxic neuropathy: a study of 52 patients. Neurology. 1993. 43: 358-62.Year
1993
Journal
Neurology
Human immunodeficiency virus infection in pregnant women under care at AIDS clinical trials centers in the United States
Citation
Pamela Stratton, Lynne M. Mofenson, Anne Willoughby. Human immunodeficiency virus infection in pregnant women under care at AIDS clinical trials centers in the United States. Obstetrics and Gynecology. 1993. 79: 364-8.Year
1993
Journal
Obstetrics and Gynecology
Potential of Population Pharmacokinetics to Reduce the Frequency of Blood Sampling Required for Estimating Kinetic Parameters in Neonates
Citation
L. Collart, Terrence F. Blaschke, F. Boucher, C. Prober. Potential of Population Pharmacokinetics to Reduce the Frequency of Blood Sampling Required for Estimating Kinetic Parameters in Neonates. Developmental Pharmacology and Therapeutics. 1992. 18: 71-80.Year
1992
Journal
Developmental Pharmacology and Therapeutics